Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia

Frequent apoptosis in the bone marrow of patients with myelodysplastic syndromes (MDS) was demonstrated on frozen sections using the terminal deoxytransferase (TdT)-mediated dUTP nick end labeling (TUNEL) method. The overall mean percentage of TUNEL-positive cells was about 17% in the bone marrow of MDS, while bone marrow from control cases exhibited a mean of 3.4% (P<0.001). To elucidate the mechanism of apoptosis in bone marrow cells of MDS, the expression of Fas antigen and Fas ligand (FasL) was examined by RT-PCR and immunohistochemistry. All MDS cases showed expression of Fas mRNA (12/12) and most exhibited an expression of Fast mRNA (10/12) by RT-PCR. Basically, control cases did not show positive signals for Fas and Fast mRNA, however, a very weak band was detected in three cases (3/10) for Fas and in one case (1/10) for Fast mRNA by RT-PCR. Immunohistochemical examination revealed positive staining for Fas (11/12) and Fast (12/12) in the bone marrow of MDS, while all the bone marrow samples from control cases were negative for anti-fas (0/15) and for anti-Fast (0/15) antibody. Double staining clarified that TUNEL-positive apoptotic cells expressed Fas antigen on the cell surface, although not all Fas-positive cells were TUNEL positive. The Fas-positive cells of MDS bone marrow included hematopoietic cells expressing CD34 antigen, neutrophil elastase, a marker for myeloid series of cells, or glycophorin A, a marker for erythroid cells. However, CD68-positive cells which were macrophage lineage cells, did not express Fas antigen strongly. In contrast, positive staining for Fast was detected in hematopoietic cells and CD68-positive cells in the bone marrow of MDS, These results suggest that the Fas-FasL system plays an important role in inducing apoptosis in the bone marrow of MDS and works in an autocrine (hematopoietic cell-hematopoietic cell interaction) and/or paracrine (hematopoietic cell-stromal cell interaction) manner.